Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three
different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse …

BACKGROUND: Ultraviolet (UV) A-1 phototherapy is now available for a variety of skin
diseases. Increasingly since 1995, there have been investigations of the efficacy of UVA-1 …

Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell
transplantation is still associated with significant morbidity and mortality. First-line treatment …

During the last three decades, ultraviolet A1 (UVA1) phototherapy has emerged as a specific
phototherapeutic modality with distinct modes of action and some well established …

Background Broad-band UVA, long-wave UVA1 and PUVA treatment have been described
as an alternative/adjunct therapeutic option in a number of inflammatory and malignant skin …

Known in part since antiquity, the salutary effects of sunlight again garnered increasing
attention in the second half of the 19th century. The development of a device for ultraviolet …

A joint working group established by the Haemato‐oncology subgroup of the British
Committee for Standards in Haematology and the British Society for Bone Marrow …

Herein we review current practice regarding the management of chronic graft-vs.-host
disease (cGvHD) in paediatric patients after allogeneic haematopoietic stem cell …

Summary Background/Purpose Ultraviolet A1 (UVA 1) phototherapy has been used for over
15 years in the United States, primarily for the treatment of localized sclerosis and various …

Long-wavelength ultraviolet A (340–400 nm UVA1) phototherapy has been reported to be
effective in atopic dermatitis, localized scleroderma and other T-cell-derived skin diseases …